Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
A. Antanasijevic, L. M. Sewall, C. A. Cottrell, D. G. Carnathan, L. E. Jimenez, J. T. Ngo, J. B. Silverman, B. Groschel, E. Georgeson, J. Bhiman, R. Bastidas, C. LaBranche, J. D. Allen, J. Copps, H. R. Perrett, K. Rantalainen, F. Cannac, Y. R. Yang, A. Torrents de la Pena, R. Froes Rocha, Z. T. Berndsen, D. Baker, N. P. King, R. W. Sanders, J. P. Moore, , A. B. Ward
Abstract
In BriefHerein, we evaluated the immunogenicity of several BG505 SOSIP-based HIV Env immunogens in the rhesus macaque animal model using a combination of serology and biophysical approaches. We applied electron cryo-microscopy for high-resolution mapping of elicited polyclonal antibody responses, which provided detailed insights into the binding modes of the most common classes of antibodies elicited by BG505 SOSIP immunogens as well as the critical differences in immunogenicity that can occur as a consequence of engineered stabilizing mutations and partial glycan occupancy at different sites. SummaryEngineered ectodomain trimer immunogens based on BG505 envelope glycoprotein are widely utilized as components of HIV vaccine development platforms. In this study, we used rhesus macaques to evaluate the immunogenicity of several stabilized BG505 SOSIP constructs both as free trimers and presented on a nanoparticle. We applied a cryoEM-based method for high-resolution mapping of polyclonal antibody responses elicited in immunized animals (cryoEMPEM). Mutational analysis coupled with neutralization assays were used to probe the neutralization potential at each epitope. We demonstrate that cryoEMPEM data can be used for rapid, high-resolution analysis of polyclonal antibody responses without the need for monoclonal antibody isolation. This approach allowed to resolve structurally distinct classes of antibodies that bind overlapping sites. In addition to comprehensive mapping of commonly targeted neutralizing and non-neutralizing epitopes in BG505 SOSIP immunogens, our analysis revealed that epitopes comprising engineered stabilizing mutations and of partially occupied glycosylation sites can be immunogenic. Graphical abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
C. A. Cottrell, J. van Schooten, … M. J. van Gils·bioRxiv·Feb 5, 2020
- High-resolution mapping of the neutralizing and binding specificities of polyclonal rabbit serum elicited by HIV Env trimer immunization
A. S. Dingens, P. Pratap, … J. D. Bloom·bioRxiv·Oct 21, 2020
- HIV envelope trimers and gp120 as immunogens to induce broadly neutralizing antibodies in cows
Pilar X. Altman, Mara Parren, … Devin Sok·bioRxiv·Mar 20, 2024
- Neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened
Y. R. Yang, L. E. McCoy, … A. B. Ward·bioRxiv·Nov 1, 2019
- Immunogenicity and Structure of a Stabilized HIV -1 clade C Env from a Pediatric Elite neutralizer in Complex with an Autologous bnAb
Swarandeep Singh, Sanjeev Kumar, … Kalpana Luthra·bioRxiv·Apr 26, 2025
- Mapping polyclonal antibody responses in non-human primates vaccinated with HIV Env trimer subunit vaccines
B. Nogal, M. Bianchi, … A. B. Ward·bioRxiv·Nov 7, 2019